1. Ultra - high transfection efficiency, whether primary cells, stem cells or hard - to - transfect cell lines, high transfection rates can be achieved. The transfection rate of most cell lines and primary cells is 50% - 70%.

2. Most extensive transfection substrates, whether protein substrates in systems biology, plasmids in structural genomics, RNA in functional genomics, or liposomes in drug research, can all be efficiently transfected.

3. Rapid transfection, as transfection does not rely on cell division, greatly reducing transfection time. In some transfection experiments, detection can be carried out 2 - 4 hours after transfection.

4. Equipped with X module and Y module, suitable for transfection of cell suspensions or adherent cells.

Nucleofector technology, a patented innovation by Lonza, combines traditional electroporation with efficient cell transfection reagents. Using optimized programs, it directly delivers foreign genes into the nucleus and cytoplasm of target cells. Unlike conventional electroporation, it offers higher transfection efficiency and cell viability for hard - to - transfect mammalian cells, such as primary cells and stem cells, with a maximum efficiency of 99%. As foreign genes enter the nucleus directly, their expression doesn't rely on cell division, and protein expression can be observed as early as 2 hours post - transfection.